Novel 2-(5-Imino-5H-isoquinolones[3,4-b]quinoxalin-7-ylmethyl)-benzonitrile (DIQ3) and Other Related Derivatives Targeting Colon Cancer Cells: Syntheses and in Vitro Models.

ACS Omega · 2019 · PMC6396124 · PMID 30842984

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

P -values of p < 0.05 (*) and p < 0.01 (**) were considered significant and highly significant, respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Novel 2-(5-Imino-5<i>H</i>-isoquinolones[3,4-<i>b</i>]quinoxalin-7-ylmethyl)-benzonitrile (<b>DIQ3</b>) and Other Related Derivatives Targeting Colon Cancer Cells: Syntheses and in Vitro Models.

The sentences